Literature DB >> 16308159

Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.

Alaa M Afify1, Sarah Craig, Augusto F G Paulino, Robert Stern.   

Abstract

The interaction between epithelial tumor cells and their surrounding stroma is important in tumor progression and metastasis. This is accomplished through a number of transmembrane receptors that interact with stromal extracellular matrix molecules. One of these receptors, CD44, binds to extracellular matrix component hyaluronic acid (HA). The purpose of this study was to evaluate the significance of HA, CD44s, and CD44v6 in benign, hyperplastic, atypical, and malignant endometrial epithelia. Archival paraffin-embedded cell blocks from proliferative endometrium (n = 11), secretory endometrium (n = 12), simple hyperplasia (n = 13), complex hyperplasia without atypia (n = 9), complex hyperplasia with atypia (n = 17), and adenocarcinoma (n = 21) were stained for HA, CD44s, and CD44v6. HA was detected throughout the normal menstrual cycle but was more intense during the secretory phase. Only during the secretory phase was CD44s expressed in the stromal cells in 11 cases (92%), whereas CD44v6 was detected in glandular epithelium in 9 (75%). CD44s was expressed in the glandular epithelium in 2 (15%) cases of simple hyperplasia, 4 (44%) of complex hyperplasia without atypia, 14 (82%) of complex hyperplasia with atypia, and in 16 (76%) of adenocarcinoma. CD44v6 was expressed in the glandular epithelium in 1 (11%) case of complex hyperplasia without atypia, 17 (100%) cases of complex hyperplasia with atypia, and in 18 (86%) cases of adenocarcinoma, but in none of the cases of simple hyperplasia. The endometrial stromal cells expressed CD44v6 in 1 (8%) case of simple hyperplasia, 6 (67%) of complex hyperplasia without atypia, 8 (47%) of complex hyperplasia with atypia, and in 3 (14%) of adenocarcinoma. We concluded that in the normal menstrual cycle, the timing of peak staining of HA and CD44s in the stroma and the up-regulation of CD44v6 in secretory glands are coincident with the period in which the endometrium is most receptive to embryo implantation. HA is more abundant in the stroma adjacent to the tumor, suggesting that interactions between tumor cells and stromal HA promote tumorigenesis. With progression from hyperplasia and with increasing atypia to adenocarcinoma, levels of stromal HA, glandular CD44v6, and glandular and stromal CD44s all increase. Thus, HA and CD44 are both involved in the development and progression of endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16308159     DOI: 10.1016/j.anndiagpath.2005.07.004

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  13 in total

1.  Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial.

Authors:  Meenakshi Singh; Kathleen M Darcy; William E Brady; Rashna Clubwala; Zachary Weber; Jon V Rittenbach; Ali Akalin; Charles W Whitney; Richard Zaino; Nilsa C Ramirez; Kimberly K Leslie
Journal:  Gynecol Oncol       Date:  2011-08-03       Impact factor: 5.482

2.  High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study.

Authors:  Ying Gao; Zi Liu; Fei Gao; Xiao-yu Meng
Journal:  BMC Cancer       Date:  2010-04-08       Impact factor: 4.430

3.  Hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in the accumulation of hyaluronan in endometrioid endometrial carcinoma.

Authors:  Timo K Nykopp; Kirsi Rilla; Markku I Tammi; Raija H Tammi; Reijo Sironen; Kirsi Hämäläinen; Veli-Matti Kosma; Seppo Heinonen; Maarit Anttila
Journal:  BMC Cancer       Date:  2010-09-27       Impact factor: 4.430

4.  Estrogen and progesterone together expand murine endometrial epithelial progenitor cells.

Authors:  Deanna M Janzen; Donghui Cheng; Amanda M Schafenacker; Daniel Y Paik; Andrew S Goldstein; Owen N Witte; Artur Jaroszewicz; Matteo Pellegrini; Sanaz Memarzadeh
Journal:  Stem Cells       Date:  2013-04       Impact factor: 6.277

5.  Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures.

Authors:  Brian J Engel; Pamela E Constantinou; Lindsey K Sablatura; Nathaniel J Doty; Daniel D Carson; Mary C Farach-Carson; Daniel A Harrington; Thomas I Zarembinski
Journal:  Adv Healthc Mater       Date:  2015-06-09       Impact factor: 9.933

6.  Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.

Authors:  Hao Jiang; Wei Zhao; Wei Shao
Journal:  Tumour Biol       Date:  2014-06-07

7.  Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma.

Authors:  Banu Dogan Gun; Burak Bahadir; Sibel Bektas; Figen Barut; Gamze Yurdakan; Nilufer Onak Kandemir; Sukru Oguz Ozdamar
Journal:  Diagn Pathol       Date:  2012-07-11       Impact factor: 2.644

8.  Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas.

Authors:  Dang-Xia Zhou; Yun-Xia Liu; Ya-Hong Xue
Journal:  Patholog Res Int       Date:  2012-02-23

9.  CD44 expression in curettage and postoperative specimens of endometrial cancer.

Authors:  Michał Wojciechowski; Tomasz Krawczyk; Janusz Śmigielski; Andrzej Malinowski
Journal:  Arch Gynecol Obstet       Date:  2014-08-17       Impact factor: 2.344

10.  Human papillomavirus infections and cancer stem cells of tumors from the uterine cervix.

Authors:  Jacqueline López; Graciela Ruíz; Jorge Organista-Nava; Patricio Gariglio; Alejandro García-Carrancá
Journal:  Open Virol J       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.